An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease-Reference-Cited by-同舟云学术

An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease

Published:2014-04-21 Issue:6 Volume:10 Page:666-674
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Langbaum Jessica B.¹²,Hendrix Suzanne B.³,Ayutyanont Napatkamon¹²,Chen Kewei¹²⁴,Fleisher Adam S.¹²,Shah Raj C.⁵⁶,Barnes Lisa L.⁵⁷⁸,Bennett David A.⁵⁷,Tariot Pierre N.¹²⁹,Reiman Eric M.¹²⁹¹⁰

Affiliation:

1. Banner Alzheimer's InstitutePhoenixAZUSA

2. Arizona Alzheimer's ConsortiumPhoenixAZUSA

3. Pentara CorporationSalt Lake CityUTUSA

4. Department of Mathematics and StatisticsArizona State UniversityTempeAZUSA

5. Rush Alzheimer's Disease CenterRush University Medical CenterChicagoILUSA

6. Department of Family MedicineRush University Medical CenterChicagoILUSA

7. Department of Neurological SciencesRush University Medical CenterChicagoILUSA

8. Department of Behavioral SciencesRush University Medical CenterChicagoILUSA

9. Department of PsychiatryUniversity of ArizonaTucsonAZUSA

10. Neurogenomics DivisionTranslational Genomics Research InstitutePhoenixAZUSA

Funder

NOMIS Stiftung

National Institute on Aging

Banner Alzheimer's Foundation

Nomis Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2014.02.002

Reference55 articles.

1. 2013 Alzheimer's disease facts and figures;Alzheimer's Association;Alzheimers Dement,2013

2. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

3. Alzheimer’s Prevention Initiative: a proposal to evaluate presymptomatic treatments as quickly as possible

4. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments;Reiman E.M.;J Alzheimers Dis,2011

5. Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral microvascular changes in healthy carriers of the APOE-ɛ4 Alzheimer's disease risk gene;PNAS Nexus;2024-08-23

2. Adult children’s education and older parents’ cognitive health in India: examining the pathways of parents’ empowered status and active engagement;Educational Gerontology;2024-02-26

3. Efficacy and safety of short‐term edaravone or nerve growth factor add‐on therapy for alcohol‐related brain damage: A multi‐centre randomised control trial;Addiction;2023-12-04

4. Milk fat globule membrane-enriched milk improves episodic memory: A randomized, parallel, double-blind, placebo-controlled trial in older adults;Journal of Functional Foods;2023-12

5. Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults;Journal of the International Neuropsychological Society;2023-11-28